WEIGAO GROUP (01066.HK) -0.010 (-0.282%) Short selling $12.10M; Ratio 17.130% announced that for the three months ended 31 March 2026, revenue was approximately RMB3.35 billion, representing a YoY increase of about 5.3%. Among its segments, general medical devices and pharmaceutical packaging recorded relatively fast revenue growth; the orthopedics and interventional segments posted slight growth; while the blood management segment experienced a decline. (ha/a)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-15 16:25.)Related News CICC: 22 Stocks Added, 24 Removed in MSCI China Index May Review; Watch Related Inflow and Outflow Impact
AASTOCKS Financial News